ストックスクリーナーアプリを入手
0.701
0.14%
0.001
アフターアワーズ：
.71
0.009
+1.28%
前日終値:
$0.70
開ける：
$0.6811
24時間の取引高:
93,134
Relative Volume:
0.40
時価総額：
$31.80M
収益：
$20.35M
当期純損益:
$-59.43M
株価収益率:
-0.6806
EPS:
-1.03
ネットキャッシュフロー:
$-30.96M
1週間 パフォーマンス:
-1.97%
1か月 パフォーマンス:
+0.11%
6か月 パフォーマンス:
-8.96%
1年 パフォーマンス:
-47.69%
1日の値動き範囲:
$0.67
$0.71
1週間の範囲:
$0.67
$0.72
52週間の値動き範囲:
$0.5011
$1.55
Dariohealth Corp Stock (DRIO) Company Profile
DRIO を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
DRIO
Dariohealth Corp
|
0.701 | 31.80M | 20.35M | -59.43M | -30.96M | -1.03 |
|
VEEV
Veeva Systems Inc
|
285.36 | 45.71B | 2.86B | 780.66M | 1.20B | 4.72 |
|
TEM
Tempus Ai Inc
|
62.07 | 9.42B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
58.85 | 9.78B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
111.55 | 8.70B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
41.16 | 6.92B | 906.14M | -52.62M | 89.62M | -0.3621 |
Dariohealth Corp Stock (DRIO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-01-29 | ダウングレード | TD Cowen | Buy → Hold |
| 2022-05-13 | アップグレード | Alliance Global Partners | Neutral → Buy |
| 2021-04-22 | 開始されました | Cowen | Outperform |
| 2021-03-23 | 開始されました | Stifel | Buy |
| 2021-02-25 | 開始されました | Cantor Fitzgerald | Overweight |
| 2021-02-01 | ダウングレード | Alliance Global Partners | Buy → Neutral |
| 2020-08-17 | 開始されました | Aegis Capital | Buy |
| 2017-08-29 | 開始されました | Aegis Capital | Buy |
| 2016-05-09 | 開始されました | Rodman & Renshaw | Buy |
すべてを表示
Dariohealth Corp (DRIO) 最新ニュース
DarioHealth (DRIO) Plans Significant Stock Offering | DRIO Stock News - GuruFocus
DarioHealth (NASDAQ:DRIO) Stock Price Passes Above 50 Day Moving Average – Here’s Why - Defense World
DarioHealth extends preferred stock conversion period By Investing.com - Investing.com Nigeria
DarioHealth extends preferred stock conversion period - Investing.com
DarioHealth Extends Conversion Period for Preferred Stocks - TipRanks
Head to Head Review: Alpha Tau Medical (NASDAQ:DRTS) & DarioHealth (NASDAQ:DRIO) - Defense World
DarioHealth (NASDAQ:DRIO) Now Covered by Litchfield Hills Research - Defense World
DarioHealth (DRIO) Coverage Initiated with 'Buy' Rating by Litch - GuruFocus
DarioHealth (DRIO) Receives Buy Rating with $3 Target from Analy - GuruFocus
DarioHealth (DRIO) Coverage Initiated with 'Buy' Rating by Litchfield Hills | DRIO Stock News - GuruFocus
DarioHealth (NASDAQ:DRIO) Stock Crosses Below 200 Day Moving Average – What’s Next? - Defense World
DarioHealth Corp. (DRIO) Reports Q1 Loss, Misses Revenue Estimates - MSN
DarioHealth Corp. (NASDAQ:DRIO) Q1 2025 Earnings Call Transcript - Insider Monkey
Stifel cuts DarioHealth stock target to $1.50, maintains buy By Investing.com - Investing.com Nigeria
Stifel cuts DarioHealth stock target to $1.50, maintains buy - Investing.com Australia
DarioHealth Reports Increased Revenue Amid Rising Losses - TipRanks
DarioHealth (DRIO) Price Target Reduced Amid Revenue Forecast Adjustments | DRIO Stock News - GuruFocus
DarioHealth earnings beat by $0.24, revenue fell short of estimates - Investing.com Canada
Earnings call transcript: DarioHealth Q1 2025 sees EPS beat, stock dips By Investing.com - Investing.com South Africa
Earnings call transcript: DarioHealth Q1 2025 sees EPS beat, stock dips - Investing.com Nigeria
DarioHealth Corp. (DRIO) reports Q1 loss, misses revenue estimates - FXStreet
DarioHealth (DRIO) Reports Q1 Revenue Below Expectations | DRIO Stock News - GuruFocus
Transcript : DarioHealth Corp., Q1 2025 Earnings Call, May 14, 2025 - marketscreener.com
DarioHealth Earnings: Revenue Up 17%, AI-Driven Cost Cuts Slash Operating Loss by 47% in Digital Health Push - Stock Titan
DarioHealth Corp. SEC 10-Q Report - TradingView
DarioHealth Corp. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com
DarioHealth (DRIO) Expected to Announce Quarterly Earnings on Wednesday - Defense World
Dario's Digital Health Solution Demonstrates Effectiveness in New Research Examining Flu Vaccination Awareness in High-Risk Populations - marketscreener.com
DarioHealth Corp. Announces New Research Published in the Journal of Medical Internet Research - marketscreener.com
DarioHealth to Report First Quarter 2025 Results on Wednesday, May 14, 2025 - The Victoria Advocate
DarioHealth Secures New Credit Agreement with Lenders - TipRanks
DarioHealth Closes Strategic Refinancing of Existing Debt Facility of up to $50 Million - citybiz
DarioHealth Closes Strategic Refinancing of Existing Debt Facili - GuruFocus
DarioHealth Closes Strategic Refinancing of Existing Debt Facility of up to $50 Million to Provide Additional Operational Flexibility and Support Growth Initiatives - GuruFocus
DarioHealth Corp. (NASDAQ:DRIO) Holdings Reduced by LPL Financial LLC - Defense World
Indo-Asian News Service - Indo-Asian News Service (IANS)
DarioHealth secures shareholder nod for stock issuances By Investing.com - Investing.com Nigeria
DarioHealth secures shareholder nod for stock issuances - Investing.com
Press Release Distribution & PR Platform - ACCESS Newswire
DarioHealth Corp. to Host Earnings Call - ACCESS Newswire
DarioHealth (NASDAQ:DRIO) Shares Pass Below Two Hundred Day Moving Average – Here’s What Happened - Defense World
DarioHealth says CFO Zvi Ben-David to retire, appoints Chen Franco-Yehuda as successor - MSN
DarioHealth announces executive changes and new CFO appointment - Investing.com Australia
DarioHealth announces executive changes and new CFO appointment By Investing.com - Investing.com India
Dariohealth Corp (DRIO) 財務データ
収益
当期純利益
現金流量
EPS
Dariohealth Corp (DRIO) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Nelson Steven Charles | Chief Commercial Officer |
Sep 10 '24 |
Buy |
0.84 |
5,000 |
4,221 |
45,000 |
| Nelson Steven Charles | Chief Commercial Officer |
Sep 11 '24 |
Buy |
0.80 |
5,000 |
4,022 |
50,000 |
| Nelson Steven Charles | Chief Commercial Officer |
Sep 06 '24 |
Buy |
0.84 |
5,000 |
4,200 |
35,000 |
| Nelson Steven Charles | Chief Commercial Officer |
Sep 05 '24 |
Buy |
0.82 |
5,000 |
4,091 |
30,000 |
| Nelson Steven Charles | Chief Commercial Officer |
Sep 09 '24 |
Buy |
0.80 |
5,000 |
4,000 |
40,000 |
| Raphael Erez | Chief Executive Officer |
Aug 27 '24 |
Buy |
0.88 |
5,000 |
4,400 |
1,937,059 |
| Nelson Steven Charles | Chief Commercial Officer |
Aug 23 '24 |
Buy |
0.95 |
5,000 |
4,750 |
25,000 |
| Nelson Steven Charles | Chief Commercial Officer |
Aug 22 '24 |
Buy |
0.94 |
5,000 |
4,725 |
20,000 |
| Nelson Steven Charles | Chief Commercial Officer |
Aug 21 '24 |
Buy |
0.93 |
5,000 |
4,672 |
15,000 |
| Raphael Erez | Chief Executive Officer |
Aug 21 '24 |
Buy |
0.95 |
5,000 |
4,750 |
1,932,059 |
0.51%
0.80%
大文字化:
|
ボリューム (24 時間):